{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-014652","form_type":"8-K","ticker":"RGBP","cik":"0001589150","company_name":"Regen BioPharma Inc","filed_at":"2025-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.914790+00:00","generated_at":"2026-05-19T13:14:25.710948+00:00","sec_items":["3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Regen Biopharma issues 10M shares to CEO in settlement of $50K accrued salary","bullets":["Issued 10,000,000 common shares to CEO David R. Koos as settlement for $50,000 of accrued unpaid salary.","Shares issued under Section 4(a)(2) exempt offering; no underwriters or commissions paid.","Settlement agreement (Ex-10.1) reveals total unpaid salary of $457,113.19; only $50K settled with shares.","Post-issuance, shares outstanding increased to 31,554,704 from ~21.6M, a ~46% dilution."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-014652","json":"https://secwatch.observer/filing/0001641172-25-014652.json","markdown":"https://secwatch.observer/filing/0001641172-25-014652.md","text":"https://secwatch.observer/filing/0001641172-25-014652.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1589150/000164117225014652/0001641172-25-014652-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1589150/000164117225014652/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T13:14:25.710948+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}